Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1988 Apr;57(4):408–411. doi: 10.1038/bjc.1988.92

Low field strength magnetic resonance imaging of the spleen: results from volunteers and patients with lymphoma.

M A Richards 1, J A Webb 1, S E Jewell 1, A G Stansfeld 1, T A Lister 1, P F Wrigley 1
PMCID: PMC2246573  PMID: 3390375

Abstract

Low field strength (0.08 Tesla) magnetic resonance imaging (MRI) of the spleen with spin lattice relaxation time (T1) measurement was performed on a total of 79 healthy volunteers and 62 patients with lymphoma. Inhomogeneity was observed on the T1 images of the spleen from 25 volunteers. This was therefore considered a normal variant. The normal range of spleen T1 at 0.08 Tesla was established (362-420 msec). No influence of age on spleen T1 was detected. The range of T1 values observed in males and females was similar, although the mean spleen T1 for females was significantly longer than that for males. The sensitivity of T1 measurement for the detection of lymphoma in the spleen was poor, particularly for patients with Hodgkin's disease. In a minority of untreated patients, however, a spleen T1 value outside the normal range may indicate the presence of lymphoma in the spleen. A significant decrease in spleen T1 following treatment was observed in 9 patients who underwent serial scanning.

Full text

PDF
408

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aisenberg A. C., Goldman J. M., Raker J. W., Wang C. C. Spleen involvement at the onset of Hodgkin's disease. Ann Intern Med. 1971 Apr;74(4):544–547. doi: 10.7326/0003-4819-74-4-544. [DOI] [PubMed] [Google Scholar]
  2. Bakker C. J., Vriend J. Proton spin-lattice relaxation studies of tissue response to radiotherapy in mice. Phys Med Biol. 1983 Apr;28(4):331–340. doi: 10.1088/0031-9155/28/4/001. [DOI] [PubMed] [Google Scholar]
  3. Best J. J., Blackledge G., Forbes W. S., Todd I. D., Eddleston B., Crowther D., Isherwood I. Computed tomography of abdomen in staging and clinical management of lymphoma. Br Med J. 1978 Dec 16;2(6153):1675–1677. doi: 10.1136/bmj.2.6153.1675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chabner B. A., Johnson R. E., Chretien P. B., Schein P. S., Young R. C., Canellos C. P., Hubbard S. H., Anderson T., Rosenoff S. H., DeVita V. T. Percutaneous liver biopsy, peritoneoscopy and laparotomy: an assessment of relative merits in the lymphomata. Br J Cancer Suppl. 1975 Mar;2:242–247. [PMC free article] [PubMed] [Google Scholar]
  5. Glatstein E., Trueblood H. W., Enright L. P., Rosenberg S. A., Kaplan H. S. Surgical staging of abdominal involvement in unselected patients with Hodgkin's disease. Radiology. 1970 Nov;97(2):425–432. doi: 10.1148/97.2.425. [DOI] [PubMed] [Google Scholar]
  6. Goffinet D. R., Castellino R. A., Kim H., Dorfman R. F., Fuks Z., Rosenberg S. A., Nelsen T., Kaplan H. S. Staging laparotomies in unselected previously untreated patients with non-Hodgkin's lymphomas. Cancer. 1973 Sep;32(3):672–681. doi: 10.1002/1097-0142(197309)32:3<672::aid-cncr2820320321>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  7. Kadin M. E., Glatstein E., Dorfman R. F. Clinicopathologic studies of 117 untreated patients subjected to laparotomy for the staging of Hodgkin's disease. Cancer. 1971 Jun;27(6):1277–1294. doi: 10.1002/1097-0142(197106)27:6<1277::aid-cncr2820270602>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  8. Ling C. R., Foster M. A. DAB-induced changes in NMR relaxation times, water and iron content of rat tissue. Br J Cancer. 1980 Jul;42(1):148–152. doi: 10.1038/bjc.1980.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Milder M. S., Larson S. M., Bagley C. M., Jr, DeVita V. T., Jr, Johnson R. E., Johnston G. S. Liver-spleen scan in Hodgkin's disease. Cancer. 1973 Apr;31(4):826–834. doi: 10.1002/1097-0142(197304)31:4<826::aid-cncr2820310410>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  10. Richards M. A., Gregory W. M., Webb J. A., Jewell S. E., Reznek R. H. Reproducibility of spin lattice relaxation time (T1) measurement using an 0.08 tesla MD 800 magnetic resonance imager. Br J Radiol. 1987 Mar;60(711):241–244. doi: 10.1259/0007-1285-60-711-241. [DOI] [PubMed] [Google Scholar]
  11. Richards M. A. Magnetic resonance imaging in lymphoma--the role of spin lattice relaxation time measurement. Cancer Surv. 1987;6(2):315–341. [PubMed] [Google Scholar]
  12. Richards M. A., Webb J. A., Jewell S. E., Gregory W. M., Reznek R. H. In-vivo measurement of spin lattice relaxation time (T1) of bone marrow in healthy volunteers: the effects of age and sex. Br J Radiol. 1988 Jan;61(721):30–33. doi: 10.1259/0007-1285-61-721-30. [DOI] [PubMed] [Google Scholar]
  13. Richards M. A., Webb J. A., Jewell S. E., Gregory W. M., Reznek R. H. In-vivo measurement of spin lattice relaxation time (T1) of liver in healthy volunteers: the effects of age, sex and oral contraceptive usage. Br J Radiol. 1988 Jan;61(721):34–37. doi: 10.1259/0007-1285-61-721-34. [DOI] [PubMed] [Google Scholar]
  14. Richards M. A., Webb J. A., Reznek R. H., Davies G., Jewell S. E., Shand W. S., Wrigley P. F., Lister T. A. Detection of spread of malignant lymphoma to the liver by low field strength magnetic resonance imaging. Br Med J (Clin Res Ed) 1986 Nov 1;293(6555):1126–1128. doi: 10.1136/bmj.293.6555.1126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rosenberg S. A., Dorfman R. F., Kaplan H. S. The value of sequential bone marrow biopsy and laparotomy and splenectomy in a series of 127 consecutive untreated patients with non-Hodgkin's lymphoma. Br J Cancer Suppl. 1975 Mar;2:221–227. [PMC free article] [PubMed] [Google Scholar]
  16. Silverman S., DeNardo G. l., Glatstein E., Lipton M. J. Evaluation of the liver and spleen in Hodgkin's disease. II. The value of splenic scintigraphy. Am J Med. 1972 Mar;52(3):362–366. doi: 10.1016/0002-9343(72)90024-1. [DOI] [PubMed] [Google Scholar]
  17. Stein R. S., Ultmann J. E., Byrne G. E., Jr, Moran E. M., Golomb H. M., Oetzel N. Bone marrow involvement in non-Hodgkin's lymphoma: implications for staging and therapy. Cancer. 1976 Feb;37(2):629–636. doi: 10.1002/1097-0142(197602)37:2<629::aid-cncr2820370204>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  18. Sutcliffe S. B., Wrigley P. F., Smyth J. F., Webb J. A., Tucker A. K., Beard M. E., Irving M., Stansfeld A. G., Malpas J. S., Crowther D. Intensive investigation in management of Hodgkin's disease. Br Med J. 1976 Dec 4;2(6048):1343–1347. doi: 10.1136/bmj.2.6048.1343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Zornoza J., Ginaldi S. Computed tomography in hepatic lymphoma. Radiology. 1981 Feb;138(2):405–410. doi: 10.1148/radiology.138.2.7455122. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES